IN192750B - - Google Patents

Info

Publication number
IN192750B
IN192750B IN1170DE2000A IN192750B IN 192750 B IN192750 B IN 192750B IN 1170DE2000 A IN1170DE2000 A IN 1170DE2000A IN 192750 B IN192750 B IN 192750B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Deepak Murpani
Rajiv Malik
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN1170DE2000 priority Critical patent/IN192750B/en
Priority to AU2002220968A priority patent/AU2002220968A1/en
Priority to EP01270300A priority patent/EP1343481A4/en
Priority to PCT/IB2001/002354 priority patent/WO2002047607A2/en
Publication of IN192750B publication Critical patent/IN192750B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
IN1170DE2000 2000-12-15 2000-12-15 IN192750B (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN1170DE2000 IN192750B (es) 2000-12-15 2000-12-15
AU2002220968A AU2002220968A1 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form
EP01270300A EP1343481A4 (en) 2000-12-15 2001-12-07 PROCESS FOR THE PREPARATION OF A QUICKLY SOLUBLE DOSAGE FORM
PCT/IB2001/002354 WO2002047607A2 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1170DE2000 IN192750B (es) 2000-12-15 2000-12-15

Publications (1)

Publication Number Publication Date
IN192750B true IN192750B (es) 2004-05-15

Family

ID=11097139

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1170DE2000 IN192750B (es) 2000-12-15 2000-12-15

Country Status (4)

Country Link
EP (1) EP1343481A4 (es)
AU (1) AU2002220968A1 (es)
IN (1) IN192750B (es)
WO (1) WO2002047607A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
KR100503949B1 (ko) * 2003-04-28 2005-07-26 주식회사유한양행 염산 온단세트론의 쓴맛을 효과적으로 은폐한 경구용 구강속붕해정 조성물
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
WO2005062722A2 (en) * 2003-11-21 2005-07-14 Sun Pharmaceutical Industries Limited Fexofenadine containing pharmaceutical formulation
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
EP2217213B1 (en) 2007-10-31 2017-05-24 Johnson & Johnson Consumer Inc. Orally disintegrative dosage form
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US8784781B2 (en) 2009-09-24 2014-07-22 Mcneil-Ppc, Inc. Manufacture of chewing gum product with radiofrequency
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CN102258497B (zh) * 2011-08-18 2013-01-09 海南良方医药有限公司 一种拉米夫定片剂组合物及其制备方法
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN103432091A (zh) * 2013-09-13 2013-12-11 钟术光 一种性能改善的片剂及其制备方法
CN106068120B (zh) 2014-01-10 2021-03-23 强生消费者公司 使用射频和有损耗的包衣粒子制造片剂的方法
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CN113490486A (zh) 2019-02-22 2021-10-08 康特伦英国斯温顿捷迪斯有限公司 最小化团聚、曝气和保持包含布洛芬的药物组合物的包衣
EP3927314B1 (en) 2019-02-22 2023-08-23 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
JP2023526098A (ja) 2020-05-18 2023-06-20 オレクソ・アクチエボラゲット 薬物送達のための新しい医薬組成物
AR127780A1 (es) 2021-11-25 2024-02-28 Orexo Ab Nueva composición farmacéutica que comprende adrenalina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1258428A (en) * 1984-06-28 1989-08-15 Nalinkant C. Damani Antacid composition
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
DE69429119T2 (de) * 1993-07-09 2002-07-18 R.P. Scherer Corp., Troy Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
GB2293099A (en) * 1994-09-15 1996-03-20 Mailway Packaging Group Ltd Drug formulation
PT893992E (pt) * 1996-04-16 2004-06-30 Novartis Consumer Health Sa Formas de dosagem oral de desintegracao rapida
WO1999043306A1 (en) * 1998-02-26 1999-09-02 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.

Also Published As

Publication number Publication date
EP1343481A2 (en) 2003-09-17
WO2002047607A3 (en) 2003-03-20
AU2002220968A1 (en) 2002-06-24
WO2002047607A2 (en) 2002-06-20
EP1343481A4 (en) 2004-03-17

Similar Documents

Publication Publication Date Title
BE2016C059I2 (es)
BE2014C019I2 (es)
BE2013C060I2 (es)
BE2012C016I2 (es)
BE2010C018I2 (es)
BRPI0113085B8 (es)
CZ20120293A3 (es)
BE2010C040I2 (es)
BRPI0113372A8 (es)
CN3141437S (es)
CN3144700S (es)
AU2001273056A2 (es)
AU2001294354A8 (es)
CL2001002979A1 (es)
CN3134543S (es)
CN3134731S (es)
CN3134893S (es)
CN3135488S (es)
CN3135584S (es)
CN3136262S (es)
CN3139842S (es)
CN3140016S (es)
CN3141006S (es)
CN3141399S (es)
AU2000270908A8 (es)